Resources
Filter by Topic
- Infographic
For a more comprehensive view of the patient journey and experience, life sciences organizations must turn data into insights. Panalgo’s Instant Health Data (IHD) platform...
- Case Study
In this case study, we dive into how this company educated employees in data science analytics techniques across departments with various skillsets and fostered a...
- Blogs
Today’s life sciences companies need efficient ways to turn real-world data into meaningful insights. To explore how Panalgo’s Instant Health Data (IHD) and IHD Cloud...
- Case Study
With Panalgo’s IHD, a company successfully accelerated its ability to derive actionable insights from real-world data, leading to tangible business benefits.
- Press Releases
Global provider of pharma intelligence solutions joins the ranks of Waymo, Nvidia, Duolingo, and more
- Case Study
A biopharma manufacturer developing a rare disease treatment needed to quantify its potential patient population.
- Case Study
When a medical device company was preparing to launch a new product, it turned to Panalgo to generate robust data for an HEOR study on...
Worries and Hopes for Healthcare Delivery in 2024
Industry experts from Norstella – a family of brands that includes, Citeline, the Dedham Group, Evaluate, MMIT, and Panalgo, and whose data and technologies support
Building Effective Real World Evidence Studies to Support New Indications for Established Products
In this article from PharmExec.com, Panalgo’s Executive Director of Solutions Meg Richards, and Dr. Samy Suissa, Founder of the Canadian Network for Observational Drug Effect
Leaning Into RWE: The IRA is Here, So Now’s the Time
Manufacturers are continuing to wrestle with the effects of the Inflation Reduction Act (IRA) on their business plans and revenue streams. Although some of the
Conclusions from Copenhagen: Highlights of ISPOR EU 2023
ISPOR Europe 2023, with the largest number of delegates on record (5,600) was held in wonderful, wonderful Copenhagen (cue the Danny Kaye waltz) last week.
How RWE Improves Evidence Generation Across the Product Life Cycle
Real-world evidence (RWE) is crucial for biopharmaceutical companies and other life sciences organizations to develop the right products for the marketplace. RWE is a powerful
Linking Real-World Data is Like Making a Fine, Blended Wine
In the healthcare and life sciences industries, developments like the explosion of real-world data, new regulatory programs and frameworks, and a focus on AI and
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization